Turk Ilac ve Serumnayi (IST:TRILC) Cash Flow from Financing: ₺-607 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.20
GF Value ₺3.65
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi Cash Flow from Financing?

Turk Ilac ve Serumnayi IST:TRILC -2.44% 61 Cash Flow from Financing is ₺-607 Mil as of Sep. 2025. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.65 (Possible Value Trap). The stock has 11 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2025, Turk Ilac ve Serumnayi paid ₺0 Mil more to buy back shares than it received from issuing new shares. It received ₺235 Mil from issuing more debt. It paid ₺0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ₺0 Mil from paying cash dividends to shareholders. It spent ₺217 Mil on other financial activities. In all, Turk Ilac ve Serumnayi earned ₺17 Mil on financial activities for the three months ended in Sep. 2025.


Turk Ilac ve Serumnayi  (IST:TRILC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Turk Ilac ve Serumnayi's issuance of stock for the three months ended in Sep. 2025 was ₺0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Turk Ilac ve Serumnayi's repurchase of stock for the three months ended in Sep. 2025 was ₺0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Turk Ilac ve Serumnayi's net issuance of debt for the three months ended in Sep. 2025 was ₺235 Mil. Turk Ilac ve Serumnayi received ₺235 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Turk Ilac ve Serumnayi's net issuance of preferred for the three months ended in Sep. 2025 was ₺0 Mil. Turk Ilac ve Serumnayi paid ₺0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Turk Ilac ve Serumnayi's cash flow for dividends for the three months ended in Sep. 2025 was ₺0 Mil. Turk Ilac ve Serumnayi received ₺0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Turk Ilac ve Serumnayi's other financing for the three months ended in Sep. 2025 was ₺-217 Mil. Turk Ilac ve Serumnayi spent ₺217 Mil on other financial activities.


Turk Ilac ve Serumnayi Cash Flow from Financing Related Terms


Turk Ilac ve Serumnayi Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi Cash Flow from Financing Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
-19.73 135.88 -170.07 -371.95 536.68

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -324.60 -379.39 -136.60 -108.65 17.22
IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Turk Ilac ve Serumnayi's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Turk Ilac ve Serumnayi's Cash from Financing for the quarter that ended in Sep. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-607 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of ₺-607 Mil mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a Cash Flow from Financing of ₺-607 Mil as of Sep. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Turk Ilac ve Serumnayi and its competitors.
Is Turk Ilac ve Serumnayi's Cash Flow from Financing too high?
Turk Ilac ve Serumnayi's current Cash Flow from Financing is ₺-607 Mil. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's Cash Flow from Financing compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's Cash Flow from Financing of ₺-607 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Drug Manufacturers company?
A good Cash Flow from Financing depends on the Drug Manufacturers industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current Cash Flow from Financing is ₺-607 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.65, compared to a current price of ₺1.20 — trading 67.1% below its estimated fair value. The current Cash Flow from Financing is ₺-607 Mil. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current Cash Flow from Financing is ₺-607 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.20 is trading 67.1% below its estimated GF Value™ of ₺3.65. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • Cash Flow from Financing: ₺-607 Mil
  • GF Value™: ₺3.65 vs. price of ₺1.20 (67.1% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.20
Price
₺3.65
GF Value